XML 66 R45.htm IDEA: XBRL DOCUMENT v2.4.1.9
SHAREHOLDERS' EQUITY (Tables)
12 Months Ended
Dec. 31, 2014
SHAREHOLDERS' EQUITY [Abstract]  
Schedule of Share Option Activity
   
2014
   
2013
   
2012
 
   
Number
of share options
   
Weighted average exercise price
   
Number
of share options
   
Weighted average exercise price
   
Number
     of share         options 
   
Weighted average exercise price
 
Outstanding as of beginning of year
    8,066,749     $ 6.31       4,351,487     $ 15.21       4,483,793     $ 14.97  
Granted
    746,431       5.81       5,402,961       4.54       30,336       12.64  
Exercised
    (762,607     4.36       (23,932     4.35       (125,260     4.36  
Terminated
    (30,901     35.40       (4,273     52.79       (411     63.57  
Forfeited
    (482,453     5.86       (1,659,494     23.76       (36,971     20.23  
Outstanding as of end of year
    7,537,219       6.37       8,066,749       6.31       4,351,487       15.21  
Options exercisable as of end of year
    1,834,281     $ 11.54       2,419,180     $ 9.03       3,553,662     $ 14.28  

Schedule of Information about Share Options Outstanding
Outstanding as of December 31, 2014
   
Exercisable as of December 31, 2014
 
Range of exercise
Prices
   
Number outstanding
   
Weighted average remaining contractual life
(in years)
   
Weighted average exercise price
   
Number exercisable
   
Weighted average exercise price
 
$ 3.15       10,000       5.25     $ 3.15       10,000     $ 3.15  
  4.35-13.20       6,733,734       5.27       4.81       1,030,796       5.39  
  15.90-20.85       418,202       3.34       16.85       418,202       16.85  
 $ 21.00-32.25       375,283       2.37     $ 22.76       375,283     $ 22.76  
          7,537,219                       1,834,281          

Schedule of Intrinsic and Fair Values for Options Exercised
     
Year Ended December 31,
 
     
2014
   
2013
   
2012
 
 
The intrinsic value of options exercised
  $ 3,680     $ 42     $ 927  
 
The original fair value of options exercised
  $ 2,661     $ 158     $ 819  
Schedule of Stock-Based Compensation Expense in Statement of Operations
     
Year Ended December 31,
 
     
2014
   
2013
   
2012
 
 
Component of income before provision for income taxes:
 
 
Cost of revenue
  $ 753     $ 597     $ 902  
 
Research and development, net
    1,034       527       714  
 
Selling, general and administrative
    2,897       1,658       4,121  
 
Stock-based compensation expense
  $ 4,684     $ 2,782     $ 5,737  
Schedule of Fair Value of Options Granted
 
 
 
  2014     2013     2012  
 
Risk-free interest rate
  1.3%-1.8%     0.8%-1.8%     0.6%-1.0%  
 
Expected life of options
  4.75 years     4.75 years     4.75 years  
 
Expected annual volatility
  47%-57%     51%-65%     52%-55%  
 
Expected dividend yield
  None     None     None